195 related articles for article (PubMed ID: 24146467)
1. Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.
Herrera-Arellano A; López-Villegas EO; Rodríguez-Tovar AV; Zamilpa A; Jiménez-Ferrer E; Tortoriello J; Martínez-Rivera MA
Afr J Tradit Complement Altern Med; 2013; 10(3):410-7. PubMed ID: 24146467
[TBL] [Abstract][Full Text] [Related]
2. Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.
Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Martínez-Rivera Mde L; Rodríguez-Tovar AV; Herrera-Alvarez S; Salas-Andonaegui ML; Nava-Xalpa MY; Méndez-Salas A; Tortoriello J
Planta Med; 2009 Apr; 75(5):466-71. PubMed ID: 19189246
[TBL] [Abstract][Full Text] [Related]
3. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
4. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole.
Herrera-Arellano A; Jiménez-Ferrer E; Vega-Pimentel AM; Martínez-Rivera Mde L; Hernández-Hernández M; Zamilpa A; Tortoriello J
Planta Med; 2004 Jun; 70(6):483-8. PubMed ID: 15241887
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural changes on clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum caused by Solanum chrysotrichum saponin SC-2.
López-Villegas EO; Herrera-Arellano A; de Los Angeles Martínez-Rivera M; Alvarez L; Cano-Nepauseno M; Marquina S; Rodríguez-Tovar AV; Tortoriello J
Planta Med; 2009 Nov; 75(14):1517-20. PubMed ID: 19551614
[TBL] [Abstract][Full Text] [Related]
6. Natural Products for Vulvovaginal Candidiasis Treatment: Evidence from Clinical Trials.
González-Burgos E; Gómez-Serranillos MP
Curr Top Med Chem; 2018; 18(15):1324-1332. PubMed ID: 30277156
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
Herrera-Arellano A; Rodríguez-Soberanes A; de los Angeles Martínez-Rivera M; Martínez-Cruz E; Zamilpa A; Alvarez L; Tortoriello J
Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
[TBL] [Abstract][Full Text] [Related]
8. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
10. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
11. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
[TBL] [Abstract][Full Text] [Related]
12. Antifungal effect of hydroethanolic extract of Fridericia chica (Bonpl.) L. G. Lohmann leaves and its therapeutic use in a vulvovaginal candidosis model.
Lima WG; Araújo MGF; Brito JCM; Castilho RO; Cardoso VN; Fernandes SOA
J Mycol Med; 2022 Aug; 32(3):101255. PubMed ID: 35219909
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Ageratina pichinchensis Extract in Patients with Vulvovaginal Candidiasis. A Randomized, Double-Blind, and Controlled Pilot Study.
Romero-Cerecero O; Islas-Garduño AL; Zamilpa A; Tortoriello J
Phytother Res; 2017 Jun; 31(6):885-890. PubMed ID: 28299831
[TBL] [Abstract][Full Text] [Related]
14. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
15. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
[TBL] [Abstract][Full Text] [Related]
16. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
17. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
19. Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment.
Dos Santos Ramos MA; de Toledo LG; Calixto GM; Bonifácio BV; de Freitas Araújo MG; Dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556451
[TBL] [Abstract][Full Text] [Related]
20. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
